Cytosurge, which is headquartered in Glattbrugg, was established in 2009 as a spin-off from the Swiss Federal Institute of Technology in Zurich (ETH). With its FluidFM technology, the company manufactures measuring devices and micromanipulation instruments for cutting-edge research in the field of nanotechnology. Over the past few years, Cytosurge has been increasingly focused on commercial applications for its FluidFM technology. The aim here, in specific terms, is to manufacture minute, complex metal components via 3D printing processes. This is of interest to companies involved in the production of watches or semiconductors, for example.
Cytosurge has now founded a spin-off that will focus exclusively on driving forward research in the area of 3D printing, as outlined in a press release. According to CEO Pascal Behr, the company’s aim here is to meet the requirements of its main target markets even more accurately. These include, among others, the semiconductor industry. The newly founded company is named Exaddon and is headquartered in Buchberg. It is being led by Edgar Hepp, a long-standing employee at Cytosurge. Hepp commented in the press release: “Exaddon AG is now responsible for all Cytosurge projects in the context of 3D printing. It will manage and further develop these projects”. Cytosurge and Exaddon will continue to work closely together.
Weitere News
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space